The Role of Standards in Facilitating Bioprinting Technology: Inroads Made, More Work to be Done
Part of the “Boosting Bioethics & Bioprinting” Webinar Series
Date: December 5, 2024
Time: 3:00 PM – 4:00 PM EST
Location: Zoom Webinar
Join Katrina Wells, Regulatory Affairs Specialist at ARMI | BioFabUSA, as she explores the critical role of standards in advancing bioprinting technologies. This webinar will highlight the groundbreaking ASTM F3659: Standard Guide for Bioinks Used in Bioprinting, a milestone in standardizing bioprinting practices. Katrina will discuss the collaboration among industry experts and ongoing efforts to align emerging bioprinting modalities with regulatory and technological advancements.
This session is part of the NIH-funded “Boosting Bioethics & Bioprinting” Webinar Series, hosted by leading experts in bioethics, law, and engineering.
Speaker: Katrina Wells, Regulatory Affairs Specialist, ARMI | BioFabUSA
Registration: Click here to register
For more information, contact Dr. Jennifer K. Wagner at jkw131@psu.edu.
The Advanced Regenerative Manufacturing Institute (ARMI) is a member-based, nonprofit organization whose mission is to advance the bioeconomy of the United States.
BioFabUSA, a program of ARMI, is a public-private partnership with more than 170 members, including companies, academic institutions and not-for profit organizations.
ARMI BioIndustries is the full-service development and manufacturing operation within the Advanced Regenerative Manufacturing Institute.
NextFab is the first foundry for American biotechnology. The mission of NextFab is to produce technological solutions that help the United States protect against and respond to health-security threats, enhance daily medical care and add to the U.S. bioeconomy.
BioFabUSA, a program of ARMI, is a public-private partnership with more than 170 members, including companies, academic institutions and not-for profit organizations.
